Operating income increased 84.5%
Operating income changed +84.5% from the comparable as-filed period.
-$3.3M→-$514,0003 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →INSP financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory increased 40.1%
Inventory changed +40.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$121.6M→$170.5M4 prior comparisons
Inventory / revenue moved 2895 bp higher
Inventory / revenue changed +2895 basis points from the comparable as-filed period.
56.03%→84.98%3 prior comparisons
SBC / revenue moved 365 bp lower
SBC / revenue changed -365 basis points from the comparable as-filed period.
19.21%→15.55%3 prior comparisons
Cash & equivalents increased 19.5%
Cash & equivalents changed +19.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$106.9M→$127.8M2 prior comparisons
Operating margin moved 127 bp higher
Operating margin changed +127 basis points from the comparable as-filed period.
-1.53%→-0.26%3 prior comparisons
Gross margin moved 145 bp higher
Gross margin changed +145 basis points from the comparable as-filed period.
84.03%→85.48%3 prior comparisons
Revenue decreased 7.6%
Revenue changed -7.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$217.1M→$200.6M3 prior comparisons
Stock-based compensation decreased 25.2%
Stock-based compensation changed -25.2% from the comparable as-filed period.
$41.7M→$31.2M3 prior comparisons
Net income changed across a sign change
Net income changed +108.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$3.6M→$314,0002 prior comparisons
Selling, general & administrative decreased 7.7%
Selling, general & administrative changed -7.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$159.5M→$147.3M3 prior comparisons
Gross profit decreased 6.0%
Gross profit changed -6.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$182.4M→$171.5M3 prior comparisons
Research & development decreased 5.8%
Research & development changed -5.8% from the comparable as-filed period.
$26.2M→$24.7M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.